128 related articles for article (PubMed ID: 10206071)
1. Antisense oligonucleotides to the epidermal growth factor receptor.
Witters L; Kumar R; Mandal M; Bennett CF; Miraglia L; Lipton A
Breast Cancer Res Treat; 1999 Jan; 53(1):41-50. PubMed ID: 10206071
[TBL] [Abstract][Full Text] [Related]
2. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S
Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.
Zhao X; Wang N; Ren X; Zhang J; Wang J; Han J; Jia L; Liu Y; Zhang Z
J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447
[TBL] [Abstract][Full Text] [Related]
4. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.
Wang S; Lee RJ; Cauchon G; Gorenstein DG; Low PS
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3318-22. PubMed ID: 7724560
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu.
Roh H; Pippin J; Boswell C; Drebin JA
J Surg Res; 1998 Jun; 77(1):85-90. PubMed ID: 9698539
[TBL] [Abstract][Full Text] [Related]
6. [An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells].
Lin JQ; Xu ZS; Zhang HY; Yang ZW; Xu YH
Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):241-6. PubMed ID: 8571707
[TBL] [Abstract][Full Text] [Related]
7. Combined EGFR and c-Src antisense oligodeoxynucleotides encapsulated with PAMAM Denderimers inhibit HT-29 colon cancer cell proliferation.
Nourazarian AR; Najar AG; Farajnia S; Khosroushahi AY; Pashaei-Asl R; Omidi Y
Asian Pac J Cancer Prev; 2012; 13(9):4751-6. PubMed ID: 23167414
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.
He Y; Zeng Q; Drenning SD; Melhem MF; Tweardy DJ; Huang L; Grandis JR
J Natl Cancer Inst; 1998 Jul; 90(14):1080-7. PubMed ID: 9672256
[TBL] [Abstract][Full Text] [Related]
9. Receptor-mediated delivery of an antisense gene to human brain cancer cells.
Zhang Y; Jeong Lee H; Boado RJ; Pardridge WM
J Gene Med; 2002; 4(2):183-94. PubMed ID: 11933219
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor.
Rubenstein M; Glick R; Lichtor T; Mirochnik Y; Chou P; Guinan P
Med Oncol; 2001; 18(2):121-30. PubMed ID: 11778757
[TBL] [Abstract][Full Text] [Related]
11. EGFR antisense oligonucleotides encapsulated with nanoparticles decrease EGFR, MAPK1 and STAT5 expression in a human colon cancer cell line.
Najar AG; Pashaei-Asl R; Omidi Y; Farajnia S; Nourazarian AR
Asian Pac J Cancer Prev; 2013; 14(1):495-8. PubMed ID: 23534780
[TBL] [Abstract][Full Text] [Related]
12. Backbone modification alters the efficacy of antisense oligonucleotides directed against mRNA encoding either TGF-alpha or EGFR in the treatment of prostate cancer cell lines.
Rubenstein M; Slobodskoy L; Mirochnik Y; Guinan P
Methods Find Exp Clin Pharmacol; 2002 Dec; 24(10):649-52. PubMed ID: 12616956
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
Ciardiello F; Caputo R; Troiani T; Borriello G; Kandimalla ER; Agrawal S; Mendelsohn J; Bianco AR; Tortora G
Int J Cancer; 2001 Jul; 93(2):172-8. PubMed ID: 11410862
[TBL] [Abstract][Full Text] [Related]
14. The effect of epidermal growth factor receptor antisense morpholino oligomer on non-small cell lung cancer cell line.
Washio K; Aoe M; Toyooka S; Mushiake H; Tsukuda K; Shimizu N
Oncol Rep; 2003; 10(6):1967-71. PubMed ID: 14534727
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.
Alper O ; Bergmann-Leitner ES; Bennett TA; Hacker NF; Stromberg K; Stetler-Stevenson WG
J Natl Cancer Inst; 2001 Sep; 93(18):1375-84. PubMed ID: 11562388
[TBL] [Abstract][Full Text] [Related]
16. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides.
Rockwell P; O'Connor WJ; King K; Goldstein NI; Zhang LM; Stein CA
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6523-8. PubMed ID: 9177251
[TBL] [Abstract][Full Text] [Related]
17. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
18. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; Pepe S; Bianco AR; Agrawal S; Mendelsohn J; Tortora G
J Natl Cancer Inst; 1998 Jul; 90(14):1087-94. PubMed ID: 9672257
[TBL] [Abstract][Full Text] [Related]
19. Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.
Wang J; Chen P; Mrkobrada M; Hu M; Vallis KA; Reilly RM
Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1273-80. PubMed ID: 12640557
[TBL] [Abstract][Full Text] [Related]
20. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]